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Abstract
Background: Blood group O has been significantly associated with increased placental malaria
infection in primiparae and reduced risk of infection in multiparae in the Gambia, an area with
markedly seasonal malaria transmission. This study analyses the association between ABO blood
group phenotypes in relation to placental malaria pathology and birth outcomes in southern
Malawi, an area with perennial malaria transmission.
Methods: A cross-sectional study of 647 mother/child pairs delivering in Montfort Hospital,
Chikwawa District between February-June 2004 and January-July 2005 was undertaken. Maternal
peripheral and cord blood samples were obtained at delivery. Placental tissue was obtained and
malaria histology classified as active, past or no malaria infection. Birth anthropometry was
recorded. ABO blood group was measured by agglutination.
Results: In primiparae, blood group O was significantly associated with increased risk of active
placental infection (OR 2.18, 95% CI 1.15–4.6, p = 0.02) and an increased foetal-placental weight
ratio compared to non-O phenotypes (5.68 versus 5.45, p = 0.03) In multiparae blood group O was
significantly associated with less frequent active placental infection (OR 0.59, 95% CI 0.36–0.98, p
= 0.04), and a higher newborn ponderal index compared to non-O phenotypes (2.65 versus 2.55,
p = 0.007). In multivariate regression parity was independently associated with increased risk of
placental malaria (active andpast infection) in primiparae with blood group O (p = 0.034) and
reduced risk in multiparae with the same phenotype (p = 0.015).
Conclusion: Parity related susceptibility to placental malaria is associated with the mothers ABO
phenotype. This interaction influences foetal and placental growth and could be an important
modifying factor for pregnancy outcomes. The biological explanation could relate to sialic acid
dependent placental membrane differences which vary with ABO blood group.
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Background
In a previous analysis we reported for the first time an
association between the ABO blood group phenotypes,
placental malaria and pregnancy birth outcomes [1].
Blood group O was associated with an increased preva-
lence of active placental infection in primiparae and with
a reduced risk in multiparae.
It is well established in non-pregnant subjects that the risk
of acquiring P. falciparum infection with its associated
complications is determined partly by host genetic factors,
which include various haemoglobinopathies and red cell
enzyme deficiencies [2]. Several studies have examined
the effects of the ABO group phenotype on malaria risk in
non-pregnant subjects and this evidence has recently been
reviewed [3]. The limited data available which has exam-
ined clinical illness suggests that blood group A is a risk
factor for severe malaria, whereas blood group O may
offer some protection against severe disease. Epidemio-
logical evidence in community studies supports this con-
clusion although comparison between studies is difficult
because of design heterogeneity, as well as the variable
malaria transmission in the different study locations.
Our previous analysis in Gambian pregnant women iden-
tified that the well established parity-related susceptibility
to P. falciparum placental infection was associated with the
blood group O phenotype [4]. That analysis utilised a his-
toric data set which was made available from an early
study in the Gambia, an area with seasonal malaria [5]. In
the present study we sought to confirm if the association
of ABO phenotype and malaria related outcome in preg-
nancy also occurred in women living under conditions of
perennial malaria transmission in Malawi. We also
wished to assess whether the magnitude of any associa-
tion was comparable between pregnant populations in
the Gambia and Malawi.
Methods
Study Population
The study was conducted between February-June 2004
and January-July 2005 at Montfort Hospital in Chikwawa
District, Southern Malawi. Malaria is highly endemic in
this area and transmission occurs year round, but it inten-
sifies during the rainy season from December to April [6].
A total of 647 women were enrolled who attended the
hospital for delivery during the study period. Women
were approached during the first stage of labour and
informed consent was requested for participation. A ques-
tionnaire was completed by a trained midwife requesting
information on age, parity, obstetric history, bednet and
antimalarial use. Women with emergency obstetric prob-
lems (toxaemia, haemorrhage, obstructed labour or sep-
sis) or with recent blood transfusion were excluded.
Study Procedures
Maternal mid-upper-arm-circumference (MUAC) was
measured at the mid-point of the left arm. A maternal
peripheral and cord blood sample obtained after delivery
was placed in an EDTA tube. Thick and thin blood smears
were stained with Giemsa and screened for malaria para-
sites. ABO blood groups were typed by agglutination
using commercial antisera (Biotech Laboratories Ltd., Ips-
wich, Suffolk, UK). Maternal and cord haemoglobin were
measured by Haemacue (Haemacue Limited, Dronfield,
Yorks, UK)
Babies were weighed following delivery using a balance
scale to the nearest 10 gms, and crown-heel length was
measured with a length board to the nearest mm. Gesta-
tional age was assessed using a modified Ballard score [7].
Placental weight was measured to the nearest 10 gms after
large clots had been removed.
Following delivery of the placenta, a placental tissue sam-
ple was obtained by cutting a one cm cube of tissue from
both the centre and peripheral placental cotyledons.
These were fixed in 10% neutral buffered formalin. Biop-
sies were embedded in paraffin wax, sliced into thin sec-
tions and stained with Giemsa and/or haematoxylin and
eosin. Slides were examined at the Histopathology
Department, College of Medicine, Blantyre, by two
observers, with discrepant findings assessed by a patholo-
gist. Placental histology was classified according to the
classification of Bulmer et al [8], which comprises non-
infected, acute infection (presence of parasites without
pigment); chronic infection (presence of parasites and
pigment); past infection (parasites not present, pigment
present).
Categorical variables were assessed with the chi-square or
Fischer exact tests and odds ratios and their 95% confi-
dence intervals estimated. Differences between means
were assessed by ANOVA for normally distributed data or
the Mann-Whitney/Wilcoxon test. Multiple linear regres-
sion was used to analyse factors associated with anthropo-
metric outcomes. Factors with a significance level of p <
0.1 were included in the model. These were: maternal age,
parity, mid-upper arm circumference and ABO pheno-
type. The babies' ponderal index was calculated from
weight/length3 (Rohrer's index).
Results
The characteristics of the sample of women screened are
summarised in table 1. Mean age was 25.8 years (range
15–49 years) and 31.8% were primiparae. Active P. falci-
parum placental malaria was present in 124 cases (19.5%),
of which 96 were acute and 28 chronic. Past placental
malaria occurred in 111 cases (17.4%). Compared to mul-Malaria Journal 2007, 6:102 http://www.malariajournal.com/content/6/1/102
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tiparae primiparae were at increased risk of active placen-
tal malaria (22.2% versus 18.0%, p = 5.00).
Table 2 shows the association of ABO phenotypes in rela-
tion to placental malaria category and parity. There was
no association between the O blood group and risk of pla-
cental infection when parity was not taken into account.
In primiparae, blood group O was significantly associated
with increased risk of active placental malaria compared
to non-O blood groups (OR 2.18, 95% CI 1.05–4.55, p =
0.02). In multiparae blood group O was significantly
associated with less frequent active placental infection
compared to non-O phenotypes (OR 0.59, 95% CI 0.36–
0.98, p = 0.04). Blood group O was not associated with
altered risk of past placental malaria in either primiparae
(OR, 1.00, 95% CI 0.54–1.85) or multiparae (OR 0.82,
95% CI 0.46–1.43). In multivariate regression analysis
parity was independently associated with increased risk of
placental malaria (all categories) in primiparae with
blood group O (p = 0.034), and reduced risk in multi-
parae for the same phenotype (p = 0.015).
When assessing the effect of parity on the risk of placental
malaria, only O blood group mothers benefited from the
protective effect of multiparity against placental malaria
for active (primiparae vs multiparae, OR 2.51, 95% CI
1.34–4.70, p = 0.002), or active and past placental infec-
tion (primiparae vs multiparae, OR 3.83; 95% CI 2.31–
6.36, p < 0.001). There was no protective effect of parity
for active placental malaria for the other blood groups
(non-O primiparae vs multiparae, OR 1.33, 95% CI 0.83–
2.12, p = 0.2).
Birth outcomes by parity and maternal blood group phe-
notype, in relation to placental infection category, are
summarised in Table 3. There were no significant differ-
ences by ABO category between O and non-O blood
groups, for maternal or cord haemoglobin concentration,
or birth length. Among multiparae, blood group O was
associated with higher mean birthweight than for mothers
with non-O groups (3098 g versus 3017 g, p = 0.05).
When considering placental infection category, mean pla-
cental weight, was reduced in primiparae with the O phe-
notype with past or no placental infection, (p = 0.01).
The ponderal index of babies born to multiparae with
blood group O was higher than that for babies of non-O
mothers (2.68 versus 2.55, p = 0.007). In multivariate
regression including maternal MUAC, haemoglobin, par-
ity, blood group and placental malaria in the model, only
placental infection (F test 6.95, p = 0.009) and parity (F
test 6.56, p = 0.01) were independent predictive factors for
the babies ponderal index. Differences in ponderal index
were associated to parity only in blood group O women.
Among primiparae the fetal-placental weight ratio was
higher in women with blood group O (5.68 versus 5.45, p
= 0.03). In multiparae the fetal-placental ratio was also
increased in women with the O blood group, but this dif-
ference was not statistically significant (5.63 versus 5.53,
p = 0.53). In multivariate analysis, parity (p = 0.03), and
maternal haemoglobin at delivery (p = 0.03) were inde-
pendent predictive factors for the fetal-placental weight
ratio.
Discussion
We have previously reported the association between
increased prevalence of P. falciparum placental malaria
infection in primiparae and reduced prevalence in multi-
parae in Gambian women with the blood group O pheno-
type. In the present study, in women from a high malaria
transmission area of Southern Malawi, we observed a sim-
ilar association, with a comparable risk estimate for the
altered placental infection risk associated with active pla-
cental infection. In Malawian primiparae there was a 2.18
increased risk (95% CI, 1.05–4.55) of active placental
Table 1: Maternal characteristics of study sample
Characteristics n Mean or %
Age (years ± SD) 647 25.8 (6.7)
Hb (g/dl ± SD) 619 11.5 (2.6)
MUAC (cms ± SD)* 646 25.9 (2.9)
Primiparae (%) 206 31.8
Blood group (%)
A1 3 6 2 1 . 7
B1 6 1 2 5 . 7
AB 21 3.3
O3 0 9 4 9 . 3
Placental infection (%)
Active 124 19.5
Past 111 17.4
None 401 63.1
* Mid-upper arm circumferenceMalaria Journal 2007, 6:102 http://www.malariajournal.com/content/6/1/102
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malaria associated with blood group O, compared with a
2.99 estimate in the Gambia (95% CI 1.24–7.25). In mul-
tiparae the estimates for reduced risk of P. falciparum pla-
cental malaria (all histological types) in blood group O
versus non-O were comparable between the two studies
(0.45, 95% CI 0.21–0.97 in the Gambia, and 0.60, 95%
CI 0.40–0.90 in Malawi). The similarity of these findings
across two studies in different geographic locations in
Africa, with a 40 year difference between the years when
the studies were conducted, is striking. The histopatholog-
ical assessments of placental infection category were also
undertaken independently by different laboratory person-
nel. The studies in Malawi and the Gambia both showed
increased mean fetal-placental weight ratios in multiparae
with blood group O, compared to non-O phenotypes
indicating that birthweight was increased relative to pla-
cental size. The consistency of these differences across the
two studies with the associated improved placental
malaria and infant anthropometric outcomes in multi-
parae with the O phenotype supports the conclusion of a
parity-specific association of this blood group with pro-
tective malaria immunity.
In regions highly endemic for P. falciparum malaria red
cell polymorphisms that confer resistance to malaria are
widespread [9], and tolerance to malaria based on inher-
ited factors is well described. Although several studies
have analysed the association of ABO blood groups with
malaria risk and severity in areas of different malaria
endemicity, there have been no previous assessments of
the role of the ABO blood groups in relation to placental
malaria except for our previous analysis from the Gambia
[1]. The nature of the ABO histo-blood antigens has
recently been reviewed, and their population genetics and
relationship to malaria infection in non-pregnant subjects
is consistent with a pivotal role in governing infection
risk, with a group O association with protective immunity
[10].
Rosette formation in peripheral blood erythrocytes (i.e.
binding of parasite infected erythrocytes to uninfected
erythrocytes) has been associated with both the severity of
clinical malaria in children and the blood group A antigen
phenotype [11], but does not occur in placental malaria
[12]. An in vitro study in fresh clinical isolates from the
Gambia also confirmed that parasitized erythrocytes form
rosettes more readily if belonging to group A or B than
group O isolates [13]. Impaired rosette formation may
thus contribute to the innate resistance to P. falciparum
malaria that occurs in certain red cell disorders and in
individuals of the blood group O phenotype. This could
relate to enhanced parity specific immunity to placental
malaria in women with the O phenotype.
Table 3: Mean birth outcomes by parity and maternal blood group phenotype
Parity Placental Malaria Blood 
group
n Maternal Hb g/dl Cord Hb g/dl Birth weight g Length 
m
Placental weight g Ponderal 
index (‡)
Feto-
placental 
weight ratio
Primiparae Active O group 27 11.16 (2.32) 14.50 (2.40) 2803 (460) 49.11 (3.27) 504 (94) 2.37 (0.37) 5.63(0.90)
non-O 16 12.25 (3.56) 15.84 (3.39) 2747 (514) 48.18 (2.81) 510 (87) 2.43 (0.28) 5.38 (0.62)
Past or no infection O group 62 11.89 (3.03) 14.73 (2.64) 2811 (348) 49.03 (2.31) 498 (73)* 2.40 (0.32) 5.70 (0.76)†
non-O 83 11.65 (2.18) 14.78 (2.27) 2843 (424) 48.62 (3.72) 526 (84) 2.54 (0.77) 5.46 (0.79)
Multiparae Active O group 28 11.39 (2.02) 13.99 (3.20) 3007 (476) 48.27 (3.24) 559 (107) 2.69 (0.47) 5.57 (1.29)
non-O 46 11.04 (2.05) 14.11 (2.10) 2913 (540) 48.90 (3.43) 553 (113) 2.50 (0.53) 5.38 (1.16)
Past or no infection O group 178 11.49 (3.00) 14.45 (2.24) 3113 (434) 49.12 (2.83) 558 (81) 2.67 (0.70) 5.63 (0.85)
non-O 170 11.29 (2.23) 14.08 (2.54) 3050 (395) 49.38 (3.04) 553 (81) 2.56 (0.46) 5.57 (0.65)
Brackets: standard deviation
Difference between blood group O and non-O *p = 0.01; †p = 0.055
‡ birthweight/length3
Table 2: ABO phenotype by placental malaria category and parity
Placental malaria Phenotype N (%) OR compared to non-O (95% CI)
Type No A B AB O
Primiparae Active 45 5 (9.8) 11 (22) 1 28 (29) 2.18 (1.05–4.55)
Past 103 31 (61) 26 (52) 4 42 (44) 1.00 (0.54–1.85)
None 55 15 (29) 13 (26) 1 26 (27) 0.58 (0.22–1.01)
Total 203 51 50 6 96
Multiparae Active 78 21 (22) 22 (20) 5 30 (14) 0.59 (0.36–0.98)
Past 56 12 (12) 14 (13) 5 25 (12) 0.82 (0.46–1.43)
None 300 62 (65) 75 (68) 5 158 (74) 1.68 (1.12–2.52)
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Assuming incidence of P. falciparum infection is compara-
ble across different parity groups, then enhanced parity-
specific immunity in multiparae with the O phenotype
must relate to improved clearance of placental parasites.
Factors governing cytoadherence and placental parasite
sequestration are likely to play an important role since
infected erythrocytes express the unique variant surface
antigen, VAR2CSA, which adheres to the glycosoam-
inoglycan chondroitin sulphate A expressed on the surface
of syncitiotrophoblast [14]. P. falciparum alters constitu-
ents of the RBC membrane such as glycophorin band 1
and spectrin [15] contributing to antigenicity and clear-
ance by the reticuloendothelial system. Some of these
membrane proteins, including glycophorin A express
ABO phenotypes. ABO phenotypes have also been found
to be associated with the soluble endothelial cell markers
and adhesion molecules [16].
In primiparae blood group O was associated with an
increased fetal-placental weight ratio compared to moth-
ers with non-O phenotypes. In multiparae with the O
phenotype there was a higher newborn ponderal index,
and fetal-placental weight ratio although the latter was
not statistically significant. These findings are similar to
the Gambian analysis which reported a significantly
increased mean fetal-placental weight ratio in multiparae
with group O, compared to non-O phenotypes (5.74 ver-
sus 5.36, p = 0.04). The consistency of these findings
across the two studies suggests that the ABO interaction
with placental malaria has an important effect on both
placental and fetal growth. It remains to be clarified
whether there is also a gestational age effect. In the Malawi
study maternal HIV infection may have influenced fetal
growth as maternal sero-positivity for HIV infection is
reported at around 20% in this pregnant population [17].
For this reason and in view of the likelihood of other con-
founding factors, it is of interest that the effects on the
fetal-placental weight ratios were comparable across the
two studies. This supports the conclusion that the ABO
histo-blood group antigens are of critical importance in
the pathophysiology of placental malaria.
The practical implications of these findings relate not only
to the recognition of particular mother-child risk groups,
but also to the potential influence of these red cell anti-
gens for both parasite replication and the immune
response to malaria.
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